PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Promethazine Hydrochloride And Codeine Phosphate, and when can generic versions of Promethazine Hydrochloride And Codeine Phosphate launch?
Promethazine Hydrochloride And Codeine Phosphate is a drug marketed by Actavis Mid Atlantic, Amneal Pharms, Hikma, Nostrum Labs Inc, Pharm Assoc, Quagen, Tris Pharma Inc, and Wockhardt Bio Ag. and is included in eight NDAs.
The generic ingredient in PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE is codeine phosphate; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the codeine phosphate; promethazine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE?
- What are the global sales for PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE?
- What is Average Wholesale Price for PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE?
Summary for PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 5 |
DailyMed Link: | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE at DailyMed |
Pharmacology for PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
Drug Class | Opioid Agonist Phenothiazine |
Mechanism of Action | Full Opioid Agonists |